MG
NVAX icon

Marex Group’s Novavax NVAX Stock Holding History

Marex Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289K Hold
35,494
– – ﹤0.01% 789
2025
Q4 		$239K Buy
35,494
+6,829
+24% +$51.5K ﹤0.01% 789
2025
Q3 		$249K Sell
28,665
-18,317
-39% -$143K ﹤0.01% 665
2025
Q2 		$296K Sell
46,982
-1,315
-3% -$8.71K ﹤0.01% 456
2025
Q1 		$310K Buy
48,297
+23,380
+94% +$193K 0.01% 450
2024
Q4 		$200K Sell
24,917
-4,563
-15% -$44K ﹤0.01% 554
2024
Q3 		$372K Sell
29,480
-4,249
-13% -$54.9K 0.01% 350
2024
Q2 		$427K Buy
33,729
+6,431
+24% +$64.7K 0.01% 332
2024
Q1 		$130K Buy
27,298
+6,196
+29% +$28.7K ﹤0.01% 414
2023
Q4 		$101K Buy
21,102
+7,480
+55% +$45.8K ﹤0.01% 497
2023
Q3 		$98.6K Sell
13,622
-1,483
-10% -$11.8K 0.01% 203
2023
Q2 		$112K Hold
15,105
– – 0.02% 213
2023
Q1 		$105K Buy
15,105
+1,706
+13% +$15.7K 0.01% 244
2022
Q4 		$138K Buy
+13,399
New +$236K 0.02% 242

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group's NVAX Position: Q1 2026 in Review

Marex Group held its Novavax (NVAX) position steady in Q1 2026 at 35,494 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #789.

Marex Group first reported a position in NVAX in Q4 2022 and has held it in 14 quarters since. The position peaked at $427K in Q2 2024. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Marex Group held 35,494 shares of Novavax worth $289K as of Q1 2026.
  • Marex Group left its Novavax share count unchanged in Q1 2026.
  • Novavax made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #789 holding.
  • Marex Group first reported a position in Novavax in Q4 2022 and has held it in 14 quarters since.
  • Marex Group's Novavax position peaked at $427K in Q2 2024.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.